BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 19390122)

  • 1. The difference between mean plasma levels of von Willebrand factor and platelet aggregation in type 2 diabetes mellitus with and without peripheral vascular disease at Sardjito General Hospital, Yogyakarta.
    Renaldi O; Asdie RH; Sinorita H; Pramono B; Purnomo LB; Asdie AH
    Acta Med Indones; 2009 Apr; 41(2):54-8. PubMed ID: 19390122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Investigation of von Willebrand-factor as a marker of endothelial dysfunction in atherosclerotic patients].
    Horváth B; Hegedüs D; Szapáry L; Márton Z; Alexy T; Koltai K; Gyevnár Z; Juricskay I; Tóth K; Késmárky G
    Orv Hetil; 2003 Dec; 144(50):2471-6. PubMed ID: 15067986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between lower-extremity functional status and obesity in type-II diabetic patients with and without peripheral arterial disease at Dr. Sardjito Central General Hospital, Yogyakarta.
    Wangi H; Asdie RH
    Acta Med Indones; 2009 Jan; 41(1):2-5. PubMed ID: 19258672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The activity of Willebrand factor--glycoproteins IIb/IIIa complex in patients with coronary and low extremity arterial atherothrombosis and type 2 diabetes mellitus].
    Smirnova IV; Bokarev IN
    Klin Med (Mosk); 2007; 85(12):34-9. PubMed ID: 18318164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the Thr789Ala variant of the von Willebrand factor levels, on ristocetin co-factor and collagen binding capacity and its association with coronary heart disease in patients with diabetes mellitus type 2.
    Klemm T; Mehnert AK; Siegemund A; Wiesner TD; Gelbrich G; Blüher M; Paschke R
    Exp Clin Endocrinol Diabetes; 2005 Dec; 113(10):568-72. PubMed ID: 16320153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinically apparent atherosclerotic disease in diabetes is associated with an increase in platelet microparticle levels.
    Tan KT; Tayebjee MH; Lim HS; Lip GY
    Diabet Med; 2005 Dec; 22(12):1657-62. PubMed ID: 16401308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated markers of endothelial dysfunction predict type 2 diabetes mellitus in middle-aged men and women from the general population.
    Thorand B; Baumert J; Chambless L; Meisinger C; Kolb H; Döring A; Löwel H; Koenig W;
    Arterioscler Thromb Vasc Biol; 2006 Feb; 26(2):398-405. PubMed ID: 16322530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low shear stress can initiate von Willebrand factor-dependent platelet aggregation in patients with type IIB and platelet-type von Willebrand disease.
    Murata M; Fukuyama M; Satoh K; Fujimura Y; Yoshioka A; Takahashi H; Handa M; Kawai Y; Watanabe K; Ikeda Y
    J Clin Invest; 1993 Sep; 92(3):1555-8. PubMed ID: 8376606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet dysfunction in outpatients with left ventricular assist devices.
    Steinlechner B; Dworschak M; Birkenberg B; Duris M; Zeidler P; Fischer H; Milosevic L; Wieselthaler G; Wolner E; Quehenberger P; Jilma B
    Ann Thorac Surg; 2009 Jan; 87(1):131-7. PubMed ID: 19101285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma fibrinogen, haemostatic factors and prediction of peripheral arterial disease in the Edinburgh Artery Study.
    Smith FB; Lee AJ; Hau CM; Rumley A; Lowe GD; Fowkes FG
    Blood Coagul Fibrinolysis; 2000 Jan; 11(1):43-50. PubMed ID: 10691098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma indices of endothelial and platelet activation in Rheumatoid Disease: relationship to cardiovascular co-morbidity.
    Bhatia GS; Sosin MD; Patel JV; Grindulis KA; Khattak FH; Davis RC; Lip GY
    Int J Cardiol; 2009 May; 134(1):97-103. PubMed ID: 18501982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of lower plasma fetuin-a levels with peripheral arterial disease in type 2 diabetes: response to Eraso et al.
    Stefan N; Weikert C; Ix JH; Fritsche A; Häring HU
    Diabetes Care; 2010 Apr; 33(4):e55; author reply e56. PubMed ID: 20351222
    [No Abstract]   [Full Text] [Related]  

  • 13. Platelet activation and aggregation induced by recombinant von Willebrand factors reproducing four type 2B von Willebrand disease missense mutations.
    de Romeuf C; Hilbert L; Mazurier C
    Thromb Haemost; 1998 Jan; 79(1):211-6. PubMed ID: 9459349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of soluble P-selectin, von Willebrand factor, and other adhesion molecules in hypercholesterolemia and peripheral artery disease.
    Blann AD; Lip GY; Fijnheer R
    Circulation; 1999 May; 99(18):2478-9. PubMed ID: 10318743
    [No Abstract]   [Full Text] [Related]  

  • 15. Association of drinking pattern and alcohol beverage type with the prevalence of metabolic syndrome, diabetes, coronary heart disease, stroke, and peripheral arterial disease in a Mediterranean cohort.
    Athyros VG; Liberopoulos EN; Mikhailidis DP; Papageorgiou AA; Ganotakis ES; Tziomalos K; Kakafika AI; Karagiannis A; Lambropoulos S; Elisaf M
    Angiology; 2007 Dec-2008 Jan; 58(6):689-97. PubMed ID: 18216378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma von Willebrand factor and soluble E-selectin levels in stable outpatients with systolic heart failure: the Frederiksberg heart failure study.
    Chong AY; Freestone B; Lim HS; Kistorp C; Gustafsson F; Hildebrandt P; Lip GY
    Int J Cardiol; 2007 Jun; 119(1):80-2. PubMed ID: 17027106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haemostasiological parameters as risk factor for new arterial occlusions in diabetics.
    Breddin HK; Krzywanek HJ; Althoff P; Kirchmaier CM; Rosak C; Schepping M; Weichert W; Ziemen M; Schöffling K; Uberla K
    Klin Wochenschr; 1986 Oct; 64(20):1042-6. PubMed ID: 3491249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble adhesion molecule P-selectin and endothelial dysfunction in essential hypertension: implications for atherogenesis? A preliminary report.
    Lip GY; Blann AD; Zarifis J; Beevers M; Lip PL; Beevers DG
    J Hypertens; 1995 Dec; 13(12 Pt 2):1674-8. PubMed ID: 8903631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restoration of plasma von Willebrand factor deficiency is sufficient to correct thrombus formation after gene therapy for severe von Willebrand disease.
    De Meyer SF; Vandeputte N; Pareyn I; Petrus I; Lenting PJ; Chuah MK; VandenDriessche T; Deckmyn H; Vanhoorelbeke K
    Arterioscler Thromb Vasc Biol; 2008 Sep; 28(9):1621-6. PubMed ID: 18556568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of plasma soluble P-selectin and von Willebrand factor as indices of platelet activation and endothelial damage/dysfunction in high-risk patients with hypertension: a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial.
    Varughese GI; Patel JV; Tomson J; Blann AD; Hughes EA; Lip GY
    J Intern Med; 2007 Apr; 261(4):384-91. PubMed ID: 17391113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.